Clinical Trials List
Protocol NumberA14-301.Peg-Intron.RWE
Completed
2021-12-31 - 2022-12-31
Others
Recruiting3
Real world evidence of Peg-Intron® + Ribavirin to support the non-inferiority of P1101 + Ribavirin in patients with chronic HCV genotype 2 infection/
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chung-Feng Huang Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Hepatitis C
Objectives
A
Test Drug
Not applicable
Active Ingredient
Not applicable
Dosage Form
Not applicable
Dosage
Not applicable
Endpoints
A
Inclution Criteria
A
Exclusion Criteria
A
The Estimated Number of Participants
-
Taiwan
350 participants
-
Global
350 participants
